A citation-based method for searching scientific literature

P Sicinski, J L Donaher, S B Parker, T Li, A Fazeli, H Gardner, S Z Haslam, R T Bronson, S J Elledge, R A Weinberg. Cell 1995
Times Cited: 884







List of co-cited articles
1054 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
V Fantl, G Stamp, A Andrews, I Rosewell, C Dickson. Genes Dev 1995
589
42

Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen.
Frédéric Bienvenu, Siwanon Jirawatnotai, Joshua E Elias, Clifford A Meyer, Karolina Mizeracka, Alexander Marson, Garrett M Frampton, Megan F Cole, Duncan T Odom, Junko Odajima,[...]. Nature 2010
208
17


Mouse development and cell proliferation in the absence of D-cyclins.
Katarzyna Kozar, Maria A Ciemerych, Vivienne I Rebel, Hirokazu Shigematsu, Agnieszka Zagozdzon, Ewa Sicinska, Yan Geng, Qunyan Yu, Shoumo Bhattacharya, Roderick T Bronson,[...]. Cell 2004
491
16

Requirement for cyclin D3 in lymphocyte development and T cell leukemias.
Ewa Sicinska, Iannis Aifantis, Laurent Le Cam, Wojciech Swat, Christine Borowski, Qunyan Yu, Adolfo A Ferrando, Steven D Levin, Yan Geng, Harald von Boehmer,[...]. Cancer Cell 2003
260
16

Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
P Sicinski, J L Donaher, Y Geng, S B Parker, H Gardner, M Y Park, R L Robker, J S Richards, L K McGinnis, J D Biggers,[...]. Nature 1996
568
15

The requirement for cyclin D function in tumor maintenance.
Yoon Jong Choi, Xiaoyu Li, Per Hydbring, Takaomi Sanda, Joanna Stefano, Amanda L Christie, Sabina Signoretti, A Thomas Look, Andrew L Kung, Harald von Boehmer,[...]. Cancer Cell 2012
217
14

Requirement for CDK4 kinase function in breast cancer.
Qunyan Yu, Ewa Sicinska, Yan Geng, Marie Ahnström, Agnieszka Zagozdzon, Yinxin Kong, Humphrey Gardner, Hiroaki Kiyokawa, Lyndsay N Harris, Olle Stål,[...]. Cancer Cell 2006
283
14

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.
Marcos Malumbres, Rocío Sotillo, David Santamaría, Javier Galán, Ana Cerezo, Sagrario Ortega, Pierre Dubus, Mariano Barbacid. Cell 2004
558
13

Cyclin D as a therapeutic target in cancer.
Elizabeth A Musgrove, C Elizabeth Caldon, Jane Barraclough, Andrew Stone, Robert L Sutherland. Nat Rev Cancer 2011
895
13

Cell cycle, CDKs and cancer: a changing paradigm.
Marcos Malumbres, Mariano Barbacid. Nat Rev Cancer 2009
12

Living with or without cyclins and cyclin-dependent kinases.
Charles J Sherr, James M Roberts. Genes Dev 2004
816
11


Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.
David W Fry, Patricia J Harvey, Paul R Keller, William L Elliott, Maryanne Meade, Erin Trachet, Mudher Albassam, XianXian Zheng, Wilbur R Leopold, Nancy K Pryer,[...]. Mol Cancer Ther 2004
813
11

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation.
Anil M Narasimha, Manuel Kaulich, Gary S Shapiro, Yoon J Choi, Piotr Sicinski, Steven F Dowdy. Elife 2014
212
11

Cyclin D1 in breast cancer pathogenesis.
Andrew Arnold, Alexandros Papanikolaou. J Clin Oncol 2005
281
10

Development of mice expressing a single D-type cyclin.
Maria A Ciemerych, Anna M Kenney, Ewa Sicinska, Ilona Kalaszczynska, Roderick T Bronson, David H Rowitch, Humphrey Gardner, Piotr Sicinski. Genes Dev 2002
216
10


Minireview: Cyclin D1: normal and abnormal functions.
Maofu Fu, Chenguang Wang, Zhiping Li, Toshiyuki Sakamaki, Richard G Pestell. Endocrinology 2004
737
10

Cyclin D1 fine-tunes the neurogenic output of embryonic retinal progenitor cells.
Gaurav Das, Yoon Choi, Piotr Sicinski, Edward M Levine. Neural Dev 2009
47
21

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.
Lars Anders, Nan Ke, Per Hydbring, Yoon J Choi, Hans R Widlund, Joel M Chick, Huili Zhai, Marc Vidal, Stephen P Gygi, Pascal Braun,[...]. Cancer Cell 2011
326
10

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.
Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst,[...]. Breast Cancer Res 2009
861
10

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia.
S G Rane, P Dubus, R V Mettus, E J Galbreath, G Boden, E P Reddy, M Barbacid. Nat Genet 1999
580
9

CDK-independent activation of estrogen receptor by cyclin D1.
R M Zwijsen, E Wientjens, R Klompmaker, J van der Sman, R Bernards, R J Michalides. Cell 1997
581
9

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
9

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.
Lawrence M Gelbert, Shufen Cai, Xi Lin, Concepcion Sanchez-Martinez, Miriam Del Prado, Maria Jose Lallena, Raquel Torres, Rose T Ajamie, Graham N Wishart, Robert Steven Flack,[...]. Invest New Drugs 2014
297
9

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Richard S Finn, John P Crown, Istvan Lang, Katalin Boer, Igor M Bondarenko, Sergey O Kulyk, Johannes Ettl, Ravindranath Patel, Tamas Pinter, Marcus Schmidt,[...]. Lancet Oncol 2015
9

CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.
Sadhna R Vora, Dejan Juric, Nayoon Kim, Mari Mino-Kenudson, Tiffany Huynh, Carlotta Costa, Elizabeth L Lockerman, Sarah F Pollack, Manway Liu, Xiaoyan Li,[...]. Cancer Cell 2014
283
9

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
T C Wang, R D Cardiff, L Zukerberg, E Lees, A Arnold, E V Schmidt. Nature 1994
901
8

Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.
T Tsutsui, B Hesabi, D S Moons, P P Pandolfi, K S Hansel, A Koff, H Kiyokawa. Mol Cell Biol 1999
335
8

ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.
Mathew C Casimiro, Marco Crosariol, Emanuele Loro, Adam Ertel, Zuoren Yu, William Dampier, Elizabeth A Saria, Alex Papanikolaou, Timothy J Stanek, Zhiping Li,[...]. J Clin Invest 2012
88
9

The history and future of targeting cyclin-dependent kinases in cancer therapy.
Uzma Asghar, Agnieszka K Witkiewicz, Nicholas C Turner, Erik S Knudsen. Nat Rev Drug Discov 2015
866
8

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
Nicholas C Turner, Jungsil Ro, Fabrice André, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Sibylle Loibl, Cynthia Huang Bartlett, Ke Zhang,[...]. N Engl J Med 2015
878
8

Cyclin-dependent kinases.
Marcos Malumbres. Genome Biol 2014
653
8

Cdk1 is sufficient to drive the mammalian cell cycle.
David Santamaría, Cédric Barrière, Antonio Cerqueira, Sarah Hunt, Claudine Tardy, Kathryn Newton, Javier F Cáceres, Pierre Dubus, Marcos Malumbres, Mariano Barbacid. Nature 2007
657
8

Cyclin E ablation in the mouse.
Yan Geng, Qunyan Yu, Ewa Sicinska, Manjusri Das, Jürgen E Schneider, Shoumo Bhattacharya, William M Rideout, Roderick T Bronson, Humphrey Gardner, Piotr Sicinski. Cell 2003
525
8

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
Shom Goel, Qi Wang, April C Watt, Sara M Tolaney, Deborah A Dillon, Wei Li, Susanne Ramm, Adam C Palmer, Haluk Yuzugullu, Vinay Varadan,[...]. Cancer Cell 2016
225
8

CDK4/6 inhibition triggers anti-tumour immunity.
Shom Goel, Molly J DeCristo, April C Watt, Haley BrinJones, Jaclyn Sceneay, Ben B Li, Naveed Khan, Jessalyn M Ubellacker, Shaozhen Xie, Otto Metzger-Filho,[...]. Nature 2017
587
8

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
Mark W Landis, Basil S Pawlyk, Tiansen Li, Piotr Sicinski, Philip W Hinds. Cancer Cell 2006
231
7


Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform.
Biserka Mulac-Jericevic, John P Lydon, Francesco J DeMayo, Orla M Conneely. Proc Natl Acad Sci U S A 2003
397
7

Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.
Manfred Beleut, Renuga Devi Rajaram, Marian Caikovski, Ayyakkannu Ayyanan, Davide Germano, Yongwon Choi, Pascal Schneider, Cathrin Brisken. Proc Natl Acad Sci U S A 2010
211
7


Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis.
Rinath Jeselsohn, Nelson E Brown, Lisa Arendt, Ina Klebba, Miaofen G Hu, Charlotte Kuperwasser, Philip W Hinds. Cancer Cell 2010
106
7

Cdk2 knockout mice are viable.
Cyril Berthet, Eiman Aleem, Vincenzo Coppola, Lino Tessarollo, Philipp Kaldis. Curr Biol 2003
518
7

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors.
Amita Patnaik, Lee S Rosen, Sara M Tolaney, Anthony W Tolcher, Jonathan W Goldman, Leena Gandhi, Kyriakos P Papadopoulos, Muralidhar Beeram, Drew W Rasco, John F Hilton,[...]. Cancer Discov 2016
373
7

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.
Maria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, Martín A Rivas, Rosalind J Cutts, Isaac Garcia-Murillas, Alex Pearson, Marta Guzman, Olga Rodriguez, Judit Grueso,[...]. Cancer Res 2016
329
7

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
Gabriel N Hortobagyi, Salomon M Stemmer, Howard A Burris, Yoon-Sim Yap, Gabe S Sonke, Shani Paluch-Shimon, Mario Campone, Kimberly L Blackwell, Fabrice André, Eric P Winer,[...]. N Engl J Med 2016
870
7

Palbociclib and Letrozole in Advanced Breast Cancer.
Richard S Finn, Miguel Martin, Hope S Rugo, Stephen Jones, Seock-Ah Im, Karen Gelmon, Nadia Harbeck, Oleg N Lipatov, Janice M Walshe, Stacy Moulder,[...]. N Engl J Med 2016
7

Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner.
Agnès I Lukaszewicz, David J Anderson. Proc Natl Acad Sci U S A 2011
47
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.